{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T23:35:19Z","timestamp":1648510519358},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1007\/s00115-007-2255-7","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T05:10:33Z","timestamp":1174367433000},"page":"451-456","source":"Crossref","is-referenced-by-count":0,"title":["Prim\u00e4res ZNS-Lymphom w\u00e4hrend der Behandlung von Autoimmunerkrankungen mit Azathioprin"],"prefix":"10.1007","volume":"78","author":[{"given":"F.","family":"K\u00e4stner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Deckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.W.","family":"Husstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"2255_CR1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1365-2036.2001.01023.x","volume":"15","author":"Aithal","year":"2001","unstructured":"Aithal GP, Mansfield JC (2001) Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Allment Pharmacol Ther 15: 1101\u20131108","journal-title":"Allment Pharmacol Ther"},{"key":"2255_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","volume":"347","author":"Bouhnik","year":"1996","unstructured":"Bouhnik Y, Lemann M, Mary JY et al. (1996) Long-term follow-up of patients with Crohn\u2018s disease treated with azathioprine or 6-mercaptopurine. Lancet 347: 215\u2013219","journal-title":"Lancet"},{"key":"2255_CR3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00115-004-1725-4","volume":"75","author":"Buss","year":"2004","unstructured":"Buss A, Assmus A, Weidemann J et al. (2004) Diagnose eines initial infratentoriellen prim\u00e4ren B-Zell-Lymphoms des ZNS unter prolongierter Kortisonmedikation. Nervenarzt 75: 1217\u20131221","journal-title":"Nervenarzt"},{"key":"2255_CR4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/aje\/kwi311","volume":"162","author":"Chang","year":"2005","unstructured":"Chang ET, Ekstr\u00f6m Smedby K, Hjalgrim H et al. (2005) Medication Use and Risk of Non-Hodgkin\u2019s Lymphoma. Am J Epidemiol 162: 965\u2013974","journal-title":"Am J Epidemiol"},{"key":"2255_CR5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(94)92150-4","volume":"343","author":"Connell","year":"1994","unstructured":"Connell WR, Kamm MA, Dickson M et al. (1994) Long-term neoplasia risk after Azathioprine treatment in inflammatory bowel disease. Lancet 343: 1249\u20131252","journal-title":"Lancet"},{"key":"2255_CR6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10637-005-4020-8","volume":"23","author":"Coulthard","year":"2005","unstructured":"Coulthard S, Hogarth L (2005) The thiopurines: An update. Invest New Drugs 23: 523\u2013532","journal-title":"Invest New Drugs"},{"key":"2255_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.10050","volume":"69","author":"Cunningham-Rundles","year":"2002","unstructured":"Cunningham-Rundles C, Cooper DL, Duffy TP, Strauchen J (2002) Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am J Hematol 69: 171\u2013178","journal-title":"Am J Hematol"},{"key":"2255_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/gast.2002.30328","volume":"122","author":"Dayharsh","year":"2002","unstructured":"Dayharsh GA, Loftus EV, Sandborn WJ et al. (2002) Epstein-Barr Virus-Positive Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine. Gastroenterol 122: 72\u201377","journal-title":"Gastroenterol"},{"key":"2255_CR9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","volume":"2","author":"Dubinsky","year":"2004","unstructured":"Dubinsky CD (2004) Azathioprine, 6-Mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenter Hepato 2: 731\u2013743","journal-title":"Clin Gastroenter Hepato"},{"key":"2255_CR10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/gut.47.4.514","volume":"47","author":"Farrell","year":"2000","unstructured":"Farrell RJ, Ang Y, Kileen P et al. (2000) Increased incidence of non-Hodgkin\u2018s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 47: 514\u2013519","journal-title":"Gut"},{"key":"2255_CR11","doi-asserted-by":"crossref","unstructured":"Finelli PF (2005) Primary CNS lymphoma in myasthenic on long-term azathioprine. J Neuro-Onco 74: 91\u201392","DOI":"10.1007\/s11060-004-5676-1"},{"key":"2255_CR12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1046\/j.1365-2036.2002.01297.x","volume":"16","author":"Fraser","year":"2002","unstructured":"Fraser AG, Orchard TR, Robinson EM, Jewell DP (2002) Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Allment Pharmacol Ther 16: 1225\u20131232","journal-title":"Allment Pharmacol Ther"},{"key":"2255_CR13","doi-asserted-by":"crossref","unstructured":"Happe S, Milbradt O, Heese C et al. (2001) Primary central nervous system lymphoma as a neurological manifestation of AIDS stage. Nervenarzt, 72: 136\u2013142","DOI":"10.1007\/s001150050726"},{"key":"2255_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s004010051185","volume":"99","author":"Herrlinger","year":"2000","unstructured":"Herrlinger U, Klingel K, Meyermann R et al. (2000) Central nervous system Hodgkin\u2018s lymphoma without systematic manifestation: case report and review of the literature. Acta Neuropathol 99: 709\u2013714","journal-title":"Acta Neuropathol"},{"key":"2255_CR15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/1531-8249(200005)47:5<682::AID-ANA24>3.0.CO;2-Z","volume":"47","author":"Herrlinger","year":"2000","unstructured":"Herrlinger U, Weller M, Dichgans J, Melms A (2000) Association of primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis? Ann Neurol 47: 682\u2013683","journal-title":"Ann Neurol"},{"key":"2255_CR16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.38.2.258","volume":"38","author":"Hohlfeld","year":"1988","unstructured":"Hohlfeld R, Michels M, Heininger K et al. (1988) Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology 38: 258\u2013261","journal-title":"Neurology"},{"key":"2255_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00314150","volume":"220","author":"Jellinger","year":"1979","unstructured":"Jellinger K, Kothbauer P, Weiss R, Sunder-Plassmann E (1979) Primary Malignant Lymphoma of the CNS and Polyneuropathy in a Patient with Necrotizing Vasculitis Treated with Immunosuppression. J Neurol 220: 259\u2013268","journal-title":"J Neurol"},{"key":"2255_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10428199709058346","volume":"28","author":"Jensen","year":"1997","unstructured":"Jensen MK, Koch-Henriksen N, Johansen P et al. (1997) EBV-positive primary central nervous system lymphomas in monozygote twins with common variable immunodeficiency and suspected multiple sclerosis. Leuk Lymphoma 28: 187\u2013193","journal-title":"Leuk Lymphoma"},{"key":"2255_CR19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","volume":"54","author":"Kandiel","year":"2005","unstructured":"Kandiel A, Fraser AG, Korelitz BI et al. (2005) Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercapto-purine. Gut 54: 1121\u20131125","journal-title":"Gut"},{"key":"2255_CR20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1212\/WNL.36.7.1011-b","volume":"36","author":"Kern","year":"1986","unstructured":"Kern RZ, Stewart JD (1986) Listeria meningitis complicating treatment of myasthenia gravis with azathioprine and steroids. Neurology 36: 1011\u20131012","journal-title":"Neurology"},{"key":"2255_CR21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","volume":"78","author":"Kinlen","year":"1985","unstructured":"Kinlen LJ (1985) Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 78 (1A): 44\u201349","journal-title":"Am J Med"},{"key":"2255_CR22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1750-3639.2001.tb00413.x","volume":"11","author":"Kleinschmidt-DeMasters","year":"2001","unstructured":"Kleinschmidt-DeMasters BK, Gilden DH (2001) The Expanding Spectrum of Herpesvirus Infections of the Nervous System. Brain Pathol 11: 440\u2013451","journal-title":"Brain Pathol"},{"key":"2255_CR23","first-page":"200","volume":"12","author":"Knowles","year":"1999","unstructured":"Knowles DM (1999) Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 12: 200\u2013217","journal-title":"Mod Pathol"},{"key":"2255_CR24","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1111\/j.1572-0241.1999.01530.x","volume":"94","author":"Korelitz","year":"1999","unstructured":"Korelitz BI, Mirsky FJ, Fleisher MR et al. (1999) Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercatopurine. Am J Gastroenterol 94: 3248\u20133253","journal-title":"Am J Gastroenterol"},{"key":"2255_CR25","first-page":"169","volume":"56","author":"Kwon","year":"2005","unstructured":"Kwon JH, Farrell RJ (2005) The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Onco Hemat 56: 169\u2013178","journal-title":"Onco Hemat"},{"key":"2255_CR26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","volume":"121","author":"Lewis","year":"2001","unstructured":"Lewis JD, Bilker WB, Brensinger C et al. (2001) Inflammatory Bowel Disease Is Not Associated With an Increased Risk of Lymphoma. Gastroenter 121: 1080\u20131087","journal-title":"Gastroenter"},{"key":"2255_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.39.5.457","volume":"39","author":"Lewis","year":"1980","unstructured":"Lewis P, Hazleman BL, Hanka R, Roberts S (1980) Cause of death in patients with rheumatoid arthritis. Ann Rheum Dis 39: 457\u2013461","journal-title":"Ann Rheum Dis"},{"key":"2255_CR28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/art.1780150207","volume":"15","author":"Lipsmeyer","year":"1972","unstructured":"Lipsmeyer EA (1972) Development of Malignant Cerebral Lymphoma in a Patient with Systemic Lupus Erythematosus treated with Immunosuppression. Arth Rheum 15: 183\u2013186","journal-title":"Arth Rheum"},{"key":"2255_CR29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0344-0338(98)80116-7","volume":"194","author":"Mart\u00ednez","year":"1998","unstructured":"Mart\u00ednez AJ (1998) The Neuropathology of Organ Transplantation: Comparison and Contrast in 500 Patients. Pathol Res Pract 194: 473\u2013486","journal-title":"Pathol Res Pract"},{"key":"2255_CR30","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.10851","volume":"95","author":"Olson","year":"2002","unstructured":"Olson JE, Janney CA, Rao RD et al. (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma. Cancer 95: 1504\u20131510","journal-title":"Cancer"},{"key":"2255_CR31","first-page":"427","volume":"28","author":"Patel","year":"2005","unstructured":"Patel P, Moazzam N, Potti A, Mehdi SA (2005) Azathioprine induced Hodgkin Lymphoma. Am J Clin Onco 28: 427\u2013428","journal-title":"Am J Clin Onco"},{"key":"2255_CR32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1006242116122","volume":"43","author":"Paulus","year":"1999","unstructured":"Paulus W (1999) Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neuro Onco 43: 203\u2013208","journal-title":"J Neuro Onco"},{"key":"2255_CR33","first-page":"521","volume":"18","author":"Ponticelli","year":"2005","unstructured":"Ponticelli C, Campise MR (2005) Neurological complications in kidney transplant recipients. J Nephrol 18: 521\u2013528","journal-title":"J Nephrol"},{"key":"2255_CR34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","volume":"111","author":"Present","year":"1989","unstructured":"Present DH, Meltzer SJ, Korelitz BI et al. (1989) 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 111: 641\u2013649","journal-title":"Ann Intern Med"},{"key":"2255_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.43.2.128","volume":"43","author":"Prior","year":"1984","unstructured":"Prior P, Symmons DP, Brown R et al. (1984) Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis 43: 128\u2013131","journal-title":"Ann Rheum Dis"},{"key":"2255_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","volume":"56","author":"Sacktor","year":"2001","unstructured":"Sacktor N, Lyles RH, Skolasky R et al. (2001) HIV-associated neurologic disease incidence changes: Multicenter cohort study, 1990\u20131998. Neurology 56: 257\u2013260","journal-title":"Neurology"},{"key":"2255_CR37","first-page":"191","volume":"24","author":"Santaella","year":"2005","unstructured":"Santaella ML, Cox PR, Colon M et al. (2005) Rheumatologic manifestations in patients with selected primary immunodeficiencies evaluated at the University Hospital. P R Health Sci J 24: 191\u2013195","journal-title":"P R Health Sci J"},{"key":"2255_CR38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1006290032052","volume":"43","author":"Schabet","year":"1999","unstructured":"Schabet M (1999) Epidemiology of primary CNS lymphoma. Neurooncol 43: 199\u2013201","journal-title":"Neurooncol"},{"key":"2255_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(00)00385-3","volume":"181","author":"Schlegel","year":"2000","unstructured":"Schlegel U, Schmidt-Wolf IGH, Deckert M (2000) Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neuro Sci 181: 1\u201312","journal-title":"J Neuro Sci"},{"key":"2255_CR40","unstructured":"Schlegel U, Weller M (2005) Prim\u00e4re ZNS-Lymphome. In: Schlegel U, Weller M, Westphal M (Hrsg) Neuroonkologie. Thieme, Stuttgart, S\u00a0285\u2013292"},{"key":"2255_CR41","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.47.12.988","volume":"47","author":"Silman","year":"1988","unstructured":"Silman AJ, Petrie J, Hazleman B, Evans SJW (1988) Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20\u00a0year follow up study. Ann Rheum Dis 47: 988\u2013992","journal-title":"Ann Rheum Dis"},{"key":"2255_CR42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1098-2280(1999)34:2\/3<131::AID-EM12>3.0.CO;2-K","volume":"34","author":"Smith","year":"1999","unstructured":"Smith CC, Archer GE, Forster EJ et al. (1999) Smith CA, Archer GE, Forster EJ, Lambert TR, Rees RW, Lynch AM Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. Environmental Mol Mutagen 34: 131\u2013139","journal-title":"Environmental Mol Mutagen"},{"key":"2255_CR43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.TP.0000079253.06061.52","volume":"76","author":"Snanoudj","year":"2003","unstructured":"Snanoudj R, Durrbach A, Leblond V et al. (2003) Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation 76: 930\u2013937","journal-title":"Transplantation"},{"key":"2255_CR44","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00001574-200307000-00007","volume":"19","author":"Srinivasan","year":"2003","unstructured":"Srinivasan R, Lewis D (2003) Malignancy in inflammatory bowel disease. Curr Opin Gastroenterol 19: 366\u2013370","journal-title":"Curr Opin Gastroenterol"},{"key":"2255_CR45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3171\/jns.1978.49.6.0887","volume":"49","author":"Varadachari","year":"1978","unstructured":"Varadachari C, Palutke M, Climie ARW et al. (1978) Immunoblastic sarcoma (histiocytic lymphoma) of the brain with B cell markers. J Neurosurg 49: 887\u2013892","journal-title":"J Neurosurg"},{"key":"2255_CR46","doi-asserted-by":"crossref","unstructured":"van Hogezand RA, Eichhorn RF, Choudry A et al. (2002) Malignancies in Inflammatory Bowel Disease: Fact or Fiction? Scand J Gastroenterol [Suppl] 236: 48\u201353","DOI":"10.1080\/003655202320621454"},{"key":"2255_CR47","unstructured":"Volpi A (2004) Epstein-Barr Virus and Human Herpesvirus Type 8 Infections of the Central Nervous System. Herpes [Suppl 2] 11: 120A\u2013127A"},{"key":"2255_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00508-005-0311-5","volume":"117","author":"Wiesmayr","year":"2005","unstructured":"Wiesmayr S, Tabarelli W, Stelzmueller I et al. (2005) Listeria meningitis in transplant recipients. Wien Klin Wochenschr 117: 229\u2013233","journal-title":"Wien Klin Wochenschr"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2255-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-007-2255-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2255-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:08:27Z","timestamp":1558573707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-007-2255-7"}},"subtitle":["Kasuistik und Literatur\u00fcbersicht"],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["2255"],"URL":"https:\/\/doi.org\/10.1007\/s00115-007-2255-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}